One of the more promising types of cancer immunotherapy involves engineering immune cells to recognize and attack cancer. While immune cell therapies like chimeric antigen receptor (CAR) T-cell therapy have been effective for treating some cancers, untangling the mechanisms behind patient response, resistance, and development of toxicities after infusion continues to be a critical focus of ongoing research.
Download this research highlight to learn how single-cell sequencing can:
- Accelerate novel translational applications
- Advance your understanding of cancer immunotherapies